Tevogen Bio Holdings Inc.
A clinical-stage specialty immunotherapy company developing off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancer and neurological diseases. The company is developing its cytotoxic T cell (killer T cell)-based ExacTcell platform and therapeutics for viral infections, viral and non-viral induced cancers, and select neurological diseases. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | New Jersey |
Employees | 17 |
Founded | 2020 |
Financials | |
|---|---|
Market Capitalization | 119.49M |
Revenue | |
Operating Income | -45.37M |
Operating Margin | |
Net Income | -51.21M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4406 / 5373 |
Sector : Healthcare | 700 / 1144 |
Industry : Biotechnology | 317 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3963 / 5565 |
Sector : Healthcare | 680 / 1182 |
Industry : Biotechnology | 359 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4359 / 5436 |
Sector : Healthcare | 715 / 1164 |
Industry : Biotechnology | 345 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4850 / 5330 |
Sector : Healthcare | 978 / 1174 |
Industry : Biotechnology | 508 / 667 |